
Dean Blevins MD
Adrenal Disease, Diabetes, Lipid Metabolism, Thyroid
Physician
Join to View Full Profile
1124 Midtown Rd.College Station, TX 77845
Phone+1 979-977-7012
Fax+1 979-977-7013
Dr. Blevins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Dean Blevins is an endocrinologist based in College Station, TX, with expertise in adrenal disease, diabetes, lipid metabolism, and thyroid conditions. He completed his medical education at Emory University School of Medicine in 2011, followed by a residency in Internal Medicine at the University of Texas Health Science Center at Houston, and a fellowship in Endocrinology, Diabetes, and Metabolism at Baylor College of Medicine and MD Anderson Cancer Center. Since 2019, he has been practicing at Texas Endocrinology, PLLC. Dr. Blevins has authored several publications, including studies on diabetes and thyroid cancer, some of which have been frequently cited in other academic works.
Education & Training
- Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2014 - 2016
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2011 - 2014
- Emory University School of MedicineClass of 2011
Certifications & Licensure
- TX State Medical License 2016 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 25 citationsLifestyle Intervention Strategy to Treat Diabetes in Older Adults: A Randomized Controlled Trial.Alessandra Celli, Yoann Barnouin, Bryan Jiang, Dean Blevins, Georgia Colleluori
Diabetes Care. 2022-09-01 - 26 citationsHypogonadal men with type 2 diabetes mellitus have smaller bone size and lower bone turnover.Georgia Colleluori, Lina E. Aguirre, Richard I. Dorin, David Robbins, Dean Blevins
Bone. 2017-06-01 - 65 citationsAerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer.Dean P. Blevins, Ramona Dadu, Mimi Hu, Christina S. Baik, Diwakar D. Balachandran
Thyroid. 2014-05-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: